Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer

NCT04256616 · clinicaltrials.gov ↗

UNKNOWN

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

OTHER: This is an observational study that does not concern a direct intervention on patients and control subjects and does not interfere with the clinical management of patients.

Sponsor

Istituto Clinico Humanitas